Main Article Content
Hepatotoxic effects of low dose oral administration of monosodium glutamate in male albino rats
Abstract
The present study is aimed at investigating the potentials of low concentration administration of monosodium glutamate in inducing hepatotoxic effects in male albino rats. Thus, monosodium
glutamate at a dose of 5 mg/kg of body weight was administered to adult male albino rats by oral intubation. Treatment was daily for 28 days. The monosodium glutamate treatment significantly (p<0.05)
decreased the serum alkaline phosphatase activity by 71.97% but increased (p<0.05) the serum enzyme activities of aspartate aminotransferase by 66.86% and alanine aminotransferase by 9.15%. The treatment also increased (p<0.05) the serum malondialdehyde concentration by 287.15% and the serum aspartate aminotransferase-to-alanine aminotransferase ratio by 56.59%. Thus, treating rats with
monosodium glutamate at a low concentration (5 mg/kg of body weight) could be hepatotoxic without significant cholestasis or pathologies of the bone.
glutamate at a dose of 5 mg/kg of body weight was administered to adult male albino rats by oral intubation. Treatment was daily for 28 days. The monosodium glutamate treatment significantly (p<0.05)
decreased the serum alkaline phosphatase activity by 71.97% but increased (p<0.05) the serum enzyme activities of aspartate aminotransferase by 66.86% and alanine aminotransferase by 9.15%. The treatment also increased (p<0.05) the serum malondialdehyde concentration by 287.15% and the serum aspartate aminotransferase-to-alanine aminotransferase ratio by 56.59%. Thus, treating rats with
monosodium glutamate at a low concentration (5 mg/kg of body weight) could be hepatotoxic without significant cholestasis or pathologies of the bone.